Pre-Open Stock Movers

Spectrum Pharmaceuticals (Nasdaq: SPPI) 31% LOWER; announced receipt of a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the company’s Biologics License Application (BLA) for ROLONTIS® (eflapegrastim). The CRL cited deficiencies related to manufacturing and indicated that a reinspection will be necessary. The company is seeking further clarification from the FDA and plans to meet with the agency as soon as possible.

Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) 25.5% LOWER; announced positive top-line results from the Company’s PHYOX™2 pivotal clinical trial of nedosiran, which is in development as a once-monthly treatment for primary hyperoxaluria (PH), a family of ultra-rare, life-threatening genetic disorders that initially manifest with complications in the kidneys. Nedosiran is Dicerna’s lead GalXC™ RNAi therapeutic candidate and is designed to inhibit the hepatic lactate dehydrogenase (LDH) enzyme – an enzyme that catalyzes the final step in the glyoxylate metabolism pathway that can lead to oxalate overproduction in patients with PH. The PHYOX2 clinical trial included participants with PH subtypes 1 and 2 (PH1 and PH2).

Groupon (NASDAQ: GRPN) 16% HIGHER; reported Q2 EPS of $0.33, $0.36 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $266 million versus the consensus estimate of $242.47 million. Groupon sees FY2021 revenue of $950-990 million, versus the consensus of $998.1 million.

Zynga (NASDAQ: ZNGA) 15% LOWER; reported Q2 EPS of $0.02, which may not compare to the analyst estimate of $0.09. Revenue for the quarter came in at $720 million versus the consensus estimate of $713.01 million. Entered into a definitive agreement to acquire StarLark, developer of the fast-growing and second-largest mobile golf game in the world, Golf Rival, from Betta Games for $525 million in cash and stock.

Cornerstone OnDemand, Inc. (NASDAQ: CSOD) 14.8% HIGHER; entered into a definitive agreement to be acquired by Clearlake Capital Group, L.P. (together with certain of its affiliates, Clearlake), a leading private equity firm. Under the terms of the agreement, Clearlake will acquire the outstanding shares of Cornerstone common stock for $57.50 per share in cash. The transaction has an enterprise value of approximately $5.2 billion.

LiveRamp (NYSE: RAMP) 12.2% HIGHER; reported Q1 EPS of $0.09, $0.11 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $119 million versus the consensus estimate of $112.03 million.

FireEye (NASDAQ: FEYE) 11.3% LOWER; reported Q2 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $114 million versus the consensus estimate of $248.98 million. FireEye sees Q3 2021 EPS of $0.05-$0.07, versus the consensus of $0.11. FireEye sees Q3 2021 revenue of $118-122 million, versus the consensus of $257.3 million.

Robinhood Markets, Inc. (NASDAQ: HOOD) 11% HIGHER; Comments on Recent Filing of Resale Registration Statement

Carvana Co. (NYSE: CVNA) 10% HIGHER; reported Q2 EPS of $0.26, $0.67 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $3.34 billion versus the consensus estimate of $2.44 billion.

Synaptics (NASDAQ: SYNA) 7.8% HIGHER; reported Q4 EPS of $2.18, $0.18 better than the analyst estimate of $2.00. Revenue for the quarter came in at $327.8 million versus the consensus estimate of $324.45 million. Synaptics sees Q1 2022 revenue of $355-385 million, versus the consensus of $349.05 million.

Novavax, Inc. (Nasdaq: NVAX) 7.6% LOWER; Delayed Submission for U.S. Vaccine Approval

Avalara (NYSE: AVLR) 7% HIGHER; reported Q2 EPS of $0.02, $0.11 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $169.1 million versus the consensus estimate of $153.1 million. Avalara sees FY2021 revenue of $672-676 million, versus the consensus of $650 million.

Cloudflare (NYSE: NET) 6.6% LOWER; reported Q2 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $152.4 million versus the consensus estimate of $146.06 million. Cloudflare sees FY2021 EPS of ($0.11)-($0.12), versus the consensus of ($0.10). Cloudflare sees FY2021 revenue of $629-633 million, versus the consensus of $614.8 million.

Expedia (NASDAQ: EXPE) 6.3% LOWER; reported Q2 EPS of ($1.13), $0.48 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $2.11 billion versus the consensus estimate of $2 billion.

Dynavax Technologies (NASDAQ: DVAX) 5.5% HIGHER; Goldman Sachs initiates coverage with a Buy rating and a price target of $19.00.

Quidel Corp (NASDAQ: QDEL) 5.6% LOWER; reported Q2 EPS of $0.75, $0.71 worse than the analyst estimate of $1.46. Revenue for the quarter came in at $176.6 million versus the consensus estimate of $194.5 million.

Virgin Galactic Holdings (NYSE: SPCE) 5% HIGHER; reported Q2 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $570 thousand versus the consensus estimate of $380 thousand. Reopening Sales, with Prices Beginning at $450,000 Per Seat.

DraftKings (NASDAQ: DKNG) 4.9% HIGHER; reported Q2 EPS of ($0.26), $0.26 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $298 million versus the consensus estimate of $242.4 million. DraftKings sees FY2021 revenue of $1.21-1.29 billion, versus the consensus of $1.16 billion.

DiDi Global (NYSE: DIDI) 4.9% HIGHER; In Talks With State-Owned Westone To Hand Over Data Management, Monitoring - Reuters

Plug Power (NASDAQ: PLUG) 4.7% HIGHER; reported Q2 EPS of ($0.18), $0.10 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $124.6 million versus the consensus estimate of $114.02 million.

Zillow (NASDAQ: Z) (NASDAQ: ZG) 3.8% HIGHER; reported Q2 revenue of $1.3 billion versus the consensus estimate of $1.28 billion.

Ocular Therapeutix, Inc. (NASDAQ: OCUL) 3.6% LOWER; announced that Regeneron (NASDAQ: REGN) has terminated the option and license agreement collaboration between the companies. The termination became effective August 5, 2021.

Monster Beverage (NASDAQ: MNST) 3% HIGHER; reported Q2 EPS of $0.75, $0.07 better than the analyst estimate of $0.68. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.39 billion.

AIG (NYSE: AIG) 2.8% HIGHER; reported Q2 EPS of $1.52, $0.35 better than the analyst estimate of $1.17.